D. Mark McClung
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About D. Mark McClung
D. Mark McClung is recorded as COO at Sangamo Therapeutics, Inc (SGMOQ). The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $1,116,596 for D. Mark McClung in fiscal 2023, including a base salary of $513,240. Disclosed compensation is on record for 4 fiscal years. D. Mark McClung has spoken on 8 earnings calls across 1 company, most recently for Sangamo Therapeutics, Inc on November 1, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Sangamo Therapeutics, Inc (SGMOQ)
Proxy statement
Start not stated–2021-04-02
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sangamo Therapeutics, Inc
Other people whose current roles at this company are on record from its filings.
- Alexander D. Macrae CEO, Board Member
- Kathy Y. Yi CFO
- Nikunj Jain CFO, Chief Accounting Officer
- Sung H. Lee CFO
- Scott B. Willoughby General Counsel
- Alexander D. Macrae, M.B., Ch.B., Ph.D. Board Member
- Courtney Beers Board Member
- Courtney Beers, Ph.D. Board Member
- Courtney Beers, PhD. Board Member
- Dr. John Markels Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, Chief Operating Officer | $513,240 | $1,116,596 |
| 2022 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, Chief Operating Officer | $493,500 | $1,674,251 |
| 2021 | Sangamo Therapeutics, Inc (SGMOQ) | Former Executive Vice President, Chief Operating Officer | $427,673 | $1,657,289 |
| 2020 | Sangamo Therapeutics, Inc (SGMOQ) | Executive Vice President, Chief Operating Officer | $276,667 | $2,671,226 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.